Prostate Cancer Diagnostics Market Report

Global and Region Prostate Cancer Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：146
  • REPORT CODE：GMM1023284
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

    The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.

    The report details the trend, potential and market size of Prostate Cancer Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Prostate Cancer Diagnosticsmarket, defines the market attractiveness level of Prostate Cancer Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Prostate Cancer Diagnostics industry, describes the types of Prostate Cancer Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prostate Cancer Diagnostics market and the development prospects and opportunities of Prostate Cancer Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prostate Cancer Diagnostics market in Chapter 13.

    By Player:

    • Siemens Healthcare

    • Abbott

    • OPKO

    • Beckman Coulter

    • Roche

    • Myriad Genetics

    • Genomic Health

    • BioMeriux

    • Ambry Genetics

    • DiaSorin

    • MDx Health

    By Type:

    • Tumor Biomarker Tests

    • Imaging

    • Biopsy

    • Other

    By End-User:

    • age < 55

    • age 55-75

    • age > 75

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Prostate Cancer Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Prostate Cancer Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Prostate Cancer Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Prostate Cancer Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Prostate Cancer Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Prostate Cancer Diagnostics Consumption (2017-2022)

    • 7.2 United States Prostate Cancer Diagnostics Consumption (2017-2022)

    • 7.3 Europe Prostate Cancer Diagnostics Consumption (2017-2022)

    • 7.4 China Prostate Cancer Diagnostics Consumption (2017-2022)

    • 7.5 Japan Prostate Cancer Diagnostics Consumption (2017-2022)

    • 7.6 India Prostate Cancer Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Prostate Cancer Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Prostate Cancer Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Prostate Cancer Diagnostics Consumption Forecast (2022-2028)

    9 Global Prostate Cancer Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tumor Biomarker Tests Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Imaging Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Biopsy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global age < 55 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global age 55-75 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global age > 75 Consumption and Growth Rate (2017-2022)

    10 Global Prostate Cancer Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Prostate Cancer Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Tumor Biomarker Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Imaging Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Biopsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Prostate Cancer Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global age < 55 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global age 55-75 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global age > 75 Consumption Forecast and Growth Rate (2022-2028)

    11 Global Prostate Cancer Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Prostate Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Prostate Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Prostate Cancer Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Prostate Cancer Diagnostics Market Competitive Analysis

    • 14.1 Siemens Healthcare

      • 14.1.1 Siemens Healthcare Company Details

      • 14.1.2 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Siemens Healthcare Prostate Cancer Diagnostics Product and Service

    • 14.2 Abbott

      • 14.2.1 Abbott Company Details

      • 14.2.2 Abbott Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abbott Prostate Cancer Diagnostics Product and Service

    • 14.3 OPKO

      • 14.3.1 OPKO Company Details

      • 14.3.2 OPKO Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 OPKO Prostate Cancer Diagnostics Product and Service

    • 14.4 Beckman Coulter

      • 14.4.1 Beckman Coulter Company Details

      • 14.4.2 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Beckman Coulter Prostate Cancer Diagnostics Product and Service

    • 14.5 Roche

      • 14.5.1 Roche Company Details

      • 14.5.2 Roche Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Roche Prostate Cancer Diagnostics Product and Service

    • 14.6 Myriad Genetics

      • 14.6.1 Myriad Genetics Company Details

      • 14.6.2 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Myriad Genetics Prostate Cancer Diagnostics Product and Service

    • 14.7 Genomic Health

      • 14.7.1 Genomic Health Company Details

      • 14.7.2 Genomic Health Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Genomic Health Prostate Cancer Diagnostics Product and Service

    • 14.8 BioMeriux

      • 14.8.1 BioMeriux Company Details

      • 14.8.2 BioMeriux Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BioMeriux Prostate Cancer Diagnostics Product and Service

    • 14.9 Ambry Genetics

      • 14.9.1 Ambry Genetics Company Details

      • 14.9.2 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ambry Genetics Prostate Cancer Diagnostics Product and Service

    • 14.10 DiaSorin

      • 14.10.1 DiaSorin Company Details

      • 14.10.2 DiaSorin Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 DiaSorin Prostate Cancer Diagnostics Product and Service

    • 14.11 MDx Health

      • 14.11.1 MDx Health Company Details

      • 14.11.2 MDx Health Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 MDx Health Prostate Cancer Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Prostate Cancer Diagnostics

    • Figure Prostate Cancer Diagnostics Picture

    • Table Global Prostate Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Prostate Cancer Diagnostics Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Prostate Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Prostate Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Biomarker Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Imaging Consumption and Growth Rate (2017-2022)

    • Figure Global Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global age < 55 Consumption and Growth Rate (2017-2022)

    • Figure Global age 55-75 Consumption and Growth Rate (2017-2022)

    • Figure Global age > 75 Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Biomarker Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Imaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global age < 55 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global age 55-75 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global age > 75 Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Prostate Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Prostate Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Prostate Cancer Diagnostics Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Prostate Cancer Diagnostics Product and Service

    • Table OPKO (Foundation Year, Company Profile and etc.)

    • Table OPKO Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table OPKO Prostate Cancer Diagnostics Product and Service

    • Table Beckman Coulter (Foundation Year, Company Profile and etc.)

    • Table Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter Prostate Cancer Diagnostics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Prostate Cancer Diagnostics Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Prostate Cancer Diagnostics Product and Service

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Prostate Cancer Diagnostics Product and Service

    • Table BioMeriux (Foundation Year, Company Profile and etc.)

    • Table BioMeriux Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMeriux Prostate Cancer Diagnostics Product and Service

    • Table Ambry Genetics (Foundation Year, Company Profile and etc.)

    • Table Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ambry Genetics Prostate Cancer Diagnostics Product and Service

    • Table DiaSorin (Foundation Year, Company Profile and etc.)

    • Table DiaSorin Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table DiaSorin Prostate Cancer Diagnostics Product and Service

    • Table MDx Health (Foundation Year, Company Profile and etc.)

    • Table MDx Health Prostate Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table MDx Health Prostate Cancer Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US